Education
About Us
Working with TipRanks
Follow Us
Portage Biotech Inc (PRTG)
NASDAQ:PRTG
Total Valuation
Portage Biotech Inc has a market cap or net worth of $13.60M. The enterprise value is $4.68M.
Market Cap$13.60M
Enterprise Value$4.68M
Share Statistics
Portage Biotech Inc has 2,278,622 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,278,622
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Portage Biotech Inc’s return on equity (ROE) is -18.73 and return on invested capital (ROIC) is -324.01%.
Return on Equity (ROE)-18.73
Return on Assets (ROA)-9.68
Return on Invested Capital (ROIC)-324.01%
Return on Capital Employed (ROCE)-3.73
Revenue Per Employee0.00
Profits Per Employee-10.76M
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio4.36
Price to Fair Value55.94
Price to FCF-0.98
Price to Operating Cash Flow-0.94
PEG Ratio0.01
Income Statement
In the last 12 months, Portage Biotech Inc had revenue of 0.00 and earned -75.34M in profits. Earnings per share was -3.70.
Revenue0.00
Gross Profit-54.00K
Operating Income-18.25M
Pretax Income-85.70M
Net Income-75.34M
EBITDA-18.20M
Earnings Per Share (EPS)-3.70
Cash Flow
In the last 12 months, operating cash flow was -9.79M and capital expenditures 0.00, giving a free cash flow of -9.79M billion.
Operating Cash Flow-9.79M
Free Cash Flow-9.79M
Free Cash Flow per Share-4.30
Dividends & Yields
Portage Biotech Inc pays an annual dividend of $948, resulting in a dividend yield of ―
Dividend Per Share$948
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.79
52-Week Price Change61.14%
50-Day Moving Average6.98
200-Day Moving Average5.86
Relative Strength Index (RSI)45.13
Average Volume (3m)163.65K
Important Dates
Portage Biotech Inc upcoming earnings date is Aug 13, 2025, TBA (Confirmed).
Last Earnings DateFeb 26, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend DateJan 04, 2018
Financial Position
Portage Biotech Inc as a current ratio of 2.67, with Debt / Equity ratio of 2.00%
Current Ratio2.67
Quick Ratio2.67
Debt to Market Cap0.00
Net Debt to EBITDA0.27
Interest Coverage Ratio-570.41
Taxes
In the past 12 months, Portage Biotech Inc has paid -10.55M in taxes.
Income Tax-10.55M
Effective Tax Rate0.12
Enterprise Valuation
Portage Biotech Inc EV to EBITDA ratio is -12.09, with an EV/FCF ratio of -15.39.
EV to Sales0.00
EV to EBITDA-12.09
EV to Free Cash Flow-15.39
EV to Operating Cash Flow-15.39
Balance Sheet
Portage Biotech Inc has $1.76M in cash and marketable securities with $28.00K in debt, giving a net cash position of -$1.74M billion.
Cash & Marketable Securities$1.76M
Total Debt$28.00K
Net Cash-$1.74M
Net Cash Per Share-$0.76
Tangible Book Value Per Share$0.16
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Portage Biotech Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast48.91%